The "Chart of the Day" is Novo Nordisk (NVO), which showed up on Tuesday's Barchart "All-Time High" list. Novo Nordisk on Tuesday posted a new all-time high of $151.55 and closed up 1.55%. TrendSpotter in late March took a profit on a 2-month long position and just turned long again on April 2 at $145.77. In recent news on the stock, Barron's on Jan 25 ran a story that highlighted five drugs that could boost the fortunes of their drugmakers, one of which was Novo Nordisk's diabetes drug Degludec. However, Deutchebank on April 4 downgraded Novo Nordisk to Sell from Hold citing valuation concerns and pessimism about the sales prospects for the company's Victoza obesity drug. Novo Nordisk, with a market cap of $84 billion, is a world leader in insulin and diabetes care and also manufactures and markets a variety of other pharmaceutical products. Furthermore the company is the world's largest producer of industrial enzyme products. The company is based in Denmark.
No comments:
Post a Comment